The DOI matches its Crossref record; 1,155 of the 1,155 references it cites were found in a registry or an index.
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
Abstract
Neurodegenerative diseases pose a substantial socioeconomic burden on society. Unfortunately, the aging world population and lack of effective cures foreshadow a negative outlook. Although a large amount of research has been dedicated to elucidating the pathologies of neurodegenerative diseases, their principal causes remain elusive. Metal ion dyshomeostasis, proteopathy, oxidative stress, and neurotransmitter deficiencies are pathological features shared across multiple neurodegenerative disorders. In addition, these factors are proposed to be interrelated upon disease progression. Thus, the development of multifunctional compounds capable of simultaneously interacting with several pathological components has been suggested as a solution to undertake the complex pathologies of neurodegenerative diseases. In this review, we outline and discuss possible therapeutic targets in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis and molecules, previously designed or discovered as potential drug candidates for these disorders with emphasis on multifunctionality. In addition, underrepresented areas of research are discussed to indicate new directions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 1,001–1,155 of 1,155
Li, Y., Peng, P., Tang, L., Hu, Y., Hu, Y., & Sheng, R. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.07.009 · Cited by 53
New Cyclodextrin‐Bearing 8‐Hydroxyquinoline Ligands as Multifunctional Molecules
Oliveri, V., Puglisi, A., Viale, M., Aiello, C., Sgarlata, C., Vecchio, G., Clarke, J., Milton, J., & Spencer, J. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201300237 · Cited by 53
Dyrager, C., Vieira, R. P., Nyström, S., Nilsson, K. P. R., & Storr, T. (2017) · New Journal of Chemistry · doi:10.1039/c6nj01703g · Cited by 53
Oliveri, V., Grasso, G. I., Bellia, F., Attanasio, F., Viale, M., & Vecchio, G. (2015) · Inorganic Chemistry · doi:10.1021/ic502713f · Cited by 52
Zheng, H., Youdim, M. B. H., & Fridkin, M. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100069c · Cited by 52
In vitro antiamyloidogenic properties of 1,4-naphthoquinones
Bermejo‐Bescós, P., Martín‐Aragón, S., Jiménez‐Aliaga, K., Ortega, A., Molina, M. T., Buxaderas, E., Orellana, G., & Csákÿ, A. G. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.038 · Cited by 52
Cornaglia, M., Krishnamani, G. H., Mouchiroud, L., Sorrentino, V., Lehnert, T., Auwerx, J. H., & Gijs, M. A. M. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0083-6 · Cited by 52
Kochi, A., Eckroat, T. J., Green, K. D., Mayhoub, A. S., Lim, M. H., & Garneau‐Tsodikova, S. (2013) · Chemical Science · doi:10.1039/c3sc51902c · Cited by 51
Self-citationSavelieff, M. G., Liu, Y., Senthamarai, R. R. P., Korshavn, K. J., Lee, H. J., Ramamoorthy, A., & Lim, M. H. (2013) · Chemical Communications · doi:10.1039/c3cc48473d · Cited by 51
Self-citationMultifunctional iron-chelators with protective roles against neurodegenerative diseases
Nunes, A. C. C., Marques, S. M., Quintanova, C., Silva, D. F., Cardoso, S. M., Chaves, S., & Santos, M. A. (2013) · Dalton Transactions · doi:10.1039/c3dt50406a · Cited by 51
Ma, F., & Du, H. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.008 · Cited by 51
Modulation of the Aβ peptide aggregation pathway by KP1019 limits Aβ-associated neurotoxicity
Jones, M. R., Mu, C., Wang, M. C. P., Webb, M. I., Walsby, C. J., & Storr, T. (2015) · Metallomics · doi:10.1039/c4mt00252k · Cited by 50
Adherence to Cholinesterase Inhibitors in Alzheimer's Disease: A Review
Brady, R., & Weinman, J. A. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000347140 · Cited by 50
Tokuda, E., Okawa, E., Watanabe, S., & Ono, S.-I. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt517 · Cited by 50
Golko-Perez, S., Amit, T., Bar‐Am, O., Youdim, M. B. H., & Weinreb, O. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9677-6 · Cited by 50
DONEPEZIL: TOLERABILITY AND SAFETY IN ALZHEIMER'S DISEASE
Pratt, R. D., Perdomo, C. A., Surick, I. W., & Ieni, J. R. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11357.x · Cited by 50
Ferulic Acid and Alzheimer’s Disease: Promises and Pitfalls
Nabavi, S. F., Kasi, D., Malar, D. S., Sureda, A., Daglia, M., & Nabavi, S. F. (2015) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557515666150522102545 · Cited by 49
Kiaei, M., Bush, A. I., Morrison, B. M., Morrison, J. H., Cherny, R. A., Volitakis, I., Beal, M. F., & Gordon, J. W. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2000-04.2004 · Cited by 49
Wiemerslage, L., Schultz, B. J., Ganguly, A., & Lee, D. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12228 · Cited by 49
Moree, B., Yin, G., Lázaro, D. F., Munari, F., Strohäker, T., Giller, K., Becker, S., Outeiro, T. F., Zweckstetter, M., & Salafsky, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.636027 · Cited by 49
Gong, Q., Pan, L., Liu, X., Wang, Q., Huang, H., & Zhu, Y. Z. (2010) · Amino Acids · doi:10.1007/s00726-010-0685-1 · Cited by 48
Yang, L. X., Huang, K. X., Li, H. B., Gong, J. X., Wang, F., Feng, Y. B., Tao, Q. F., Wu, Y. H., Li, X. K., Wu, X. M., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900735p · Cited by 48
Identification of the Minimal Copper(II)-Binding α-Synuclein Sequence
Jackson, M. S., & Lee, J. C. (2009) · Inorganic Chemistry · doi:10.1021/ic901157w · Cited by 48
Messing, L., Decker, J. M., Joseph, M., Mandelkow�, E., & Mandelkow, E.-M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.024 · Cited by 48
In Vitro Study of α-Synuclein Protofibrils by Cryo-EM Suggests a Cu2+-Dependent Aggregation Pathway
Zhang, H., Griggs, A. M., Rochet, J., & Stanciu, L. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.04.050 · Cited by 46
Antequera, D., Bolós, M., Spuch, C., Pascual, C., Ferrer, I., Fernández‐Bachiller, M. I., Rodríguez-Franco, M. I., & Carro, E. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.009 · Cited by 46
Noël, S., Rodriguez, S. B., Sayen, S., Guillon, E., Faller, P., & Hureau, C. (2014) · Metallomics · doi:10.1039/c4mt00016a · Cited by 46
Copper(I/II), α/β‐Synuclein and Amyloid‐β: Menage à Trois?
Ricco, R. D., Valensin, D., Dell’Acqua, S., Casella, L., Hureau, C., & Faller, P. (2015) · ChemBioChem · doi:10.1002/cbic.201500425 · Cited by 46
Structural Determinants of Tau Aggregation Inhibitor Potency
Schafer, K. N., Cisek, K. K., Huseby, C. J., Chang, E. S., & Kuret, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.503474 · Cited by 45
Shepherd, A. L., Tyebji, S., Hannan, A. J., & Burrows, E. L. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0837-1 · Cited by 45
Wang, C., Wu, Z. Q., Cai, H., Xu, S., Liu, J., Jiang, J., Yao, H., Wu, X., & Xu, J. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.09.063 · Cited by 44
Shearer, J., Callan, P. E., Tran, T., & Szalai, V. A. (2010) · Chemical Communications · doi:10.1039/c0cc02446e · Cited by 44
Selenoureas and thioureas are effective superoxide radical scavengers in vitro
Takahashi, H., Nishina, A., Fukumoto, R.-H., Kimura, H., Koketsu, M., & Ishihara, H. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.08.037 · Cited by 44
Clinical trials for neuroprotection in Parkinson??s disease: overcoming angst and futility?
Hung, A. Y., & Schwarzschild, M. A. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32826388d6 · Cited by 44
Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy
Storr, T., Scott, L. E., Bowen, M. L., Green, D. E., Thompson, K. H., Schugar, H. J., & Orvig, C. (2009) · Dalton Transactions · doi:10.1039/b902545f · Cited by 44
Hirohata, M., Ono, K., Takasaki, J.-I., Takahashi, R., Ikeda, T., Morinaga, A., & Yamada, M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.05.006 · Cited by 43
Masuda, M., Hasegawa, M., Nonaka, T., Oikawa, T., Yonetani, M., Yamaguchi, Y., Kato, K., Hisanaga, S., & Goedert, M. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.01.037 · Cited by 43
Sang, Z., Qiang, X., Li, Y., Xu, R., Cao, Z., Song, Q., Wang, T. I., Zhang, X., Liu, H., Tan, Z., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.054 · Cited by 43
Exploring the Reactions of β-Amyloid (Aβ) Peptide 1–28 with AlIII and FeIII Ions
Valensin, D., Migliorini, C., Valensin, G., Gaggelli, E., Penna, G. L., Kozłowski, H., Gabbiani, C., & Luigi Messori, A. (2011) · Inorganic Chemistry · doi:10.1021/ic201069v · Cited by 42
Dgachi, Y., Sokolov, O., Luzet, V., Godyń, J., Panek, D., Bonet, A., Martin, H., Iriepa, I., Moraleda, I., García‐Iriepa, C., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.11.050 · Cited by 42
Feng, B., Li, X., Xia, J., & Wu, S. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1347163 · Cited by 42
Synthesis and characterization of IMPY derivatives that regulate metal-induced amyloid-β aggregation
Choi, J.-S., Braymer, J. J., Park, S. K., Mustafa, S., Chae, J., & Lim, M. H. (2011) · Metallomics · doi:10.1039/c0mt00077a · Cited by 41
Self-citationThe Pathophysiology of Axonal Transport in Alzheimer's Disease
Vicario-Orri, E., Opazo, C. M., & Muñoz, F. J. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-141080 · Cited by 41
Superoxide dismutase 1 modulates expression of transferrin receptor
Danzeisen, R., Achsel, T., Bederke, U., Cozzolino, M., Crosio, C., Ferri, A., Frenzel, M., Gralla, E. B., Huber, L., Ludolph, A. C., et al. (2006) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-006-0099-4 · Cited by 41
Ricco, R. D., Valensin, D., Dell’Acqua, S., Casella, L., Dorlet, P., Faller, P., & Hureau, C. (2015) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.5b00120 · Cited by 41
Okuda, M., Hijikuro, I., Fujita, Y., Wu, X., Nakayama, S., Sakata, Y., Noguchi, Y., Ogo, M., Akasofu, S., Ito, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117511 · Cited by 41
Zhou, A., Wu, H., Pan, J., Wang, X., Li, J., Wu, Z., & Hui, A. (2015) · Molecules · doi:10.3390/molecules20011304 · Cited by 41
Denya, I., Malan, S. F., Enogieru, A. B., Omoruyi, S. I., Ekpo, O. E., Kapp, E., Zindo, F. T., & Joubert, J. (2018) · MedChemComm · doi:10.1039/c7md00569e · Cited by 41
Gogoi, S., Antonio, T., Rajagopalan, S., Reith, M. E. A., Andersen, J. K., & Dutta, A. K. (2011) · ChemMedChem · doi:10.1002/cmdc.201100140 · Cited by 40
Das, B., Rajagopalan, S., Joshi, G. S., Xu, L., Luo, D., Andersen, J. K., Todi, S. V., & Dutta, A. K. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.019 · Cited by 40
Derrick, J. S., & Lim, M. H. (2015) · ChemBioChem · doi:10.1002/cbic.201402718 · Cited by 39
Self-citationCheng, X. R., Hau, B. Y. H., Veloso, A. J., Martić, S., Kraatz, H., & Kerman, K. (2012) · Analytical Chemistry · doi:10.1021/ac303181q · Cited by 39
Haque, M. M., Kim, D., Yu, Y. H., Lim, S., Kim, D. J., Chang, Y., Ha, H., & Kim, Y. K. (2014) · Amyloid · doi:10.3109/13506129.2014.929103 · Cited by 39
Kochi, A., Lee, H. J., Vithanarachchi, S. M., Padmini, V., Allen, M. J., & Lim, M. H. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150504150125 · Cited by 39
Self-citationTrujano-Ortiz, L. G., González, F. J., & Quintanar, L. (2014) · Inorganic Chemistry · doi:10.1021/ic501941a · Cited by 39
Reactivity of Diphenylpropynone Derivatives Toward Metal-Associated Amyloid-β Species
Pithadia, A. S., Kochi, A., Soper, M. T., Beck, M. W., Liu, Y., Lee, S., DeToma, A. S., Ruotolo, B. T., & Lim, M. H. (2012) · Inorganic Chemistry · doi:10.1021/ic302084g · Cited by 38
Self-citationClinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?
Nicholson, K. A., Cudkowicz, M., & Berry, J. D. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0341-2 · Cited by 38
Leal, S. S., Cristóvão, J. S., Biesemeier, A., Cardoso, I., & Gomes, C. M. (2014) · Metallomics · doi:10.1039/c4mt00278d · Cited by 38
Pan, W., Hu, K., Bai, P., Yu, L., Ma, Q., Li, T., Zhang, X., Chen, C., Peng, K., Liu, W., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.03.086 · Cited by 38
Das, B., Kandegedara, A., Xu, L., Antonio, T., Stemmler, T. L., Reith, M. E. A., & Dutta, A. K. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00356 · Cited by 38
Copper in Alzheimer’s disease: Implications in amyloid aggregation and neurotoxicity
Gámez, P., & Caballero, A. B. (2015) · AIP Advances · doi:10.1063/1.4921314 · Cited by 37
Cacciatore, I., Cornacchia, C., Fornasari, E., Baldassarre, L., Pinnen, F., Sozio, P., Stefano, A. D., Marinelli, L., Dean, A., Fulle, S., et al. (2013) · ChemMedChem · doi:10.1002/cmdc.201300295 · Cited by 37
Mechlovich, D., Amit, T., Mandel, S. A., Bar‐Am, O., Bloch, K. O., Vardi, P., & Youdim, M. B. H. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.164269 · Cited by 37
Guéroux, M., Fléau, C., Slozeck, M., Laguerre, M. S., & Pianet, I. (2017) · PubMed · doi:10.14283/jpad.2017.35 · Cited by 37
Manral, A., Saini, V., Meena, P., & Tiwari, M. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.08.024 · Cited by 36
Design and synthesis of tacrine-phenothiazine hybrids as multitarget drugs for Alzheimer’s disease
Hui, A., Chen, Y., Zhu, S.-J., Gan, C., Pan, J., & Zhou, A. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-0931-2 · Cited by 36
Abbasabadi, A. O., Javanian, A., Nikkhah, M., Meratan, A. A., Ghiasi, P., & Nemat‐Gorgani, M. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.07.007 · Cited by 36
Lee, H. J., Kerr, R. A., Korshavn, K. J., Lee, J., Kang, J., Ramamoorthy, A., Ruotolo, B. T., & Lim, M. H. (2016) · Inorganic Chemistry Frontiers · doi:10.1039/c5qi00219b · Cited by 36
Self-citationPotential synergy between tau aggregation inhibitors and tau chaperone modulators
Blair, L. J., Zhang, B., & Dickey, C. A. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt207 · Cited by 35
Tay, W. M., da Silva, G. F. Z., & Ming, L. (2013) · Inorganic Chemistry · doi:10.1021/ic301832p · Cited by 35
Chand, K., Alsoghier, H. M., Chaves, S., & Santos, M. A. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.05.005 · Cited by 35
Luo, L., Li, Y., Qiang, X., Cao, Z., Xu, R., Xia, Y., Xiao, G., Song, Q., Tan, Z., & Deng, Y. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.02.027 · Cited by 35
Telpoukhovskaia, M. A., Patrick, B. O., Rodríguez‐Rodríguez, C., & Orvig, C. (2013) · Molecular BioSystems · doi:10.1039/c3mb25600f · Cited by 34
Jones, M. R., Dyrager, C., Hoarau, M., Korshavn, K. J., Lim, M. H., Ramamoorthy, A., & Storr, T. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.04.022 · Cited by 34
Self-citationFosso, M. Y., LeVine, H., Green, K. D., Tsodikov, O. V., & Garneau‐Tsodikova, S. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01478f · Cited by 33
Ballatore, C., Crowe, A., Piscitelli, F., James, M., Lou, K., Rossidivito, G., Yao, Y., Trojanowski, J. Q., Lee, V. M. ‐., Brunden, K. R., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.05.027 · Cited by 33
Cyclodextrins promote protein aggregation posing risks for therapeutic applications
Wang, M. S., Boddapati, S. P., & Sierks, M. R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.077 · Cited by 33
Advances Toward Multifunctional Cholinesterase and β-Amyloid Aggregation Inhibitors
Panek, D., Wichur, T., Godyń, J., Pasieka, A., & Malawska, B. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0094 · Cited by 33
Tanaka, K., Kanno, T., Yanagisawa, Y., Yasutake, K., Inoue, S., Hirayama, N., & Ikeda, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087728 · Cited by 32
Lee, H. J., Korshavn, K. J., Nam, Y., Kang, J., Paul, T. J., Kerr, R. A., Youn, I. S., Özbil, M., Kim, K. S., Ruotolo, B. T., et al. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201605401 · Cited by 32
Self-citationGenistein and Folic Acid Prevent Oxidative Injury Induced by β‐Amyloid Peptide
Ding, B., Yuan, L., Yu, H., Li, L., Ma, W., Bi, Y., Feng, J., & Xiao, R. (2010) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2010.00661.x · Cited by 31
Exploring the reactivity of flavonoid compounds with metal-associated amyloid-β species
He, X., Park, H. M., Hyung, S., DeToma, A. S., Kim, C., Ruotolo, B. T., & Lim, M. H. (2012) · Dalton Transactions · doi:10.1039/c2dt12207c · Cited by 31
Self-citationLiu, W., Rabinovich, A., Nash, Y., Frenkel, D., Wang, Y., Youdim, M. B. H., & Weinreb, O. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.028 · Cited by 31
Liu, Y., Kochi, A., Pithadia, A. S., Lee, S., Nam, Y., Beck, M. W., He, X., Lee, D., & Lim, M. H. (2013) · Inorganic Chemistry · doi:10.1021/ic400851w · Cited by 30
Self-citationFuchigami, T., Yamashita, Y., Haratake, M., Ono, M., Yoshida, S., & Nakayama, M. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.03.032 · Cited by 30
Gonzalez, P., da Costa, V. C. P., Hyde, K., Wu, Q., Annunziata, O., Rizo, J., Akkaraju, G. R., & Green, K. N. (2014) · Metallomics · doi:10.1039/c4mt00161c · Cited by 30
Brazilin inhibits the Zn2+-mediated aggregation of amyloid β-protein and alleviates cytotoxicity
Guo, J., Sun, W., & Liu, F. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.09.015 · Cited by 30
Curtain, C. C., Kirby, N. M., Mertens, H. D. T., Barnham, K. J., Knott, R. B., Masters, C. L., Cappai, R., Rekas, A., Kenche, V. B., & Ryan, T. (2014) · Molecular BioSystems · doi:10.1039/c4mb00356j · Cited by 29
Rodríguez‐Rodríguez, C., Telpoukhovskaia, M. A., Alí‐Torres, J., Rodrı́guez-Santiago, L., Manso, Y., Bailey, G. A., Hidalgo, J., Sodupe, M., & Orvig, C. (2014) · Metallomics · doi:10.1039/c4mt00167b · Cited by 29
Zheng, H., Fridkin, M., & Youdim, M. B. H. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0293-1 · Cited by 29
Simoni, E., Serafini, M. M., Bartolini, M., Caporaso, R., Pinto, A., Necchi, D., Fiori, J., Andrisano, V., Minarini, A., Lanni, C., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201500422 · Cited by 29
Ono, M., & Saji, H. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11r08fm · Cited by 29
HOU, X.-Q., Yan, R., Yang, C., Zhang, L., Su, R., Liu, S., Zhang, S., He, W.-Q., Fang, S., Cheng, S., et al. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1608 · Cited by 29
Han, J., Lee, H. J., Kim, K. Y., Lee, S. J. C., Suh, J., Cho, J., Chae, J., & Lim, M. H. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00454 · Cited by 29
Self-citationPedersen, J. T., Borg, C. B., Michaels, T. C. T., Knowles, T. P. J., Faller, P., Teilum, K., & Hemmingsen, L. (2015) · ChemBioChem · doi:10.1002/cbic.201500080 · Cited by 28
Abdelhafez, O. M., Amin, K. M., Ali, H. I., Abdalla, M. M., & Batran, R. Z. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.11.005 · Cited by 28
α-Synuclein aggregation, seeding and inhibition by scyllo-inositol
Ibrahim, T., & McLaurin, J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.12.043 · Cited by 28
Manini, P., Panzella, L., Eidenberger, T., Giarra, A., Cerruti, P., Trifuoggi, M., & Napolitano, A. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b05191 · Cited by 28
Fu, Y., Mu, Y., Lei, H., Wang, P., Li, X., Leng, Q., Han, L., Qu, X., Wang, Z., & Huang, X. (2016) · Molecules · doi:10.3390/molecules21101338 · Cited by 28
Small angle X-ray scattering analysis of Cu2+-induced oligomers of the Alzheimer's amyloid β peptide
Ryan, T. M., Kirby, N. M., Mertens, H. D. T., Roberts, B. R., Barnham, K. J., Cappai, R., Pham, C. L. L., Masters, C. L., & Curtain, C. C. (2015) · Metallomics · doi:10.1039/c4mt00323c · Cited by 27
Zhang, B., Cheng, X. R., da Silva, I. S., Hung, V. W. S., Veloso, A. J., Angnes, L., & Kerman, K. (2013) · Metallomics · doi:10.1039/c3mt20106f · Cited by 27
The chelation targeting metal–Aβ40 aggregates may lead to formation of Aβ40 oligomers
Zhang, Y., Chen, L.-Y., Yin, W.-X., Yin, J., Zhang, S.-B., & Liu, C.-L. (2011) · Dalton Transactions · doi:10.1039/c1dt00020a · Cited by 26
α‐Naphthylaminopropan‐2‐ol Derivatives as BACE1 Inhibitors
Asso, V., Ghilardi, E., Bertini, S., Digiacomo, M., Granchi, C., Minutolo, F., Rapposelli, S., Bortolato, A., Moro, S., & Macchia, M. (2008) · ChemMedChem · doi:10.1002/cmdc.200800162 · Cited by 26
Yang, H., Cai, P., Liu, Q., Yang, X., Fang, S., Tang, Y.-W., Wang, C., Wang, X., & Kong, L. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.08.048 · Cited by 26
Sang, Z., Wang, K., Wang, H., Wang, H., Ma, Q., Han, X., Ye, M., Yu, L., & Liu, W. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.09.057 · Cited by 26
Two macrocyclic polyamines as modulators of metal-mediated Aβ40aggregation
Yang, Y., Chen, T., Zhu, S., Gu, X., Jia, X., Lu, Y., & Zhu, L. (2015) · Integrative Biology · doi:10.1039/c5ib00064e · Cited by 25
Martin, M. D., Calcul, L., Smith, C., Jinwal, U. K., Fontaine, S. N., Darling, A. L., Seeley, K. W., Wojtas, Ł., Narayan, M., Gestwicki, J. E., et al. (2015) · ACS Chemical Biology · doi:10.1021/cb501013w · Cited by 25
Qian, S., He, L., Mak, S., Han, Y., Ho, C., & Zuo, Z. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.10.058 · Cited by 25
Liu, T., Xia, Z., Zhang, W., Xu, J., Ge, X.-X., Li, J., Cui, Y., Qiu, Z., Xu, J., Xie, Q., et al. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.11.009 · Cited by 24
Aggregation of Aβ Alzheimer's disease‐related peptide studied by dynamic light scattering
Thunecke, M., Lobbia, A., Kosciessa, U., Dyrks, T., Oakley, A., Turner, J. D., Saenger, W., & Georgalis, Y. (1998) · Journal of Peptide Research · doi:10.1111/j.1399-3011.1998.tb01255.x · Cited by 24
Modi, G. P., Voshavar, C., Gogoi, S., Shah, M. M., Antonio, T., Reith, M. E. A., & Dutta, A. K. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500084x · Cited by 24
Linares, E., Seixas, L. V., dos Prazeres, J. N., Ladd, F. V. L., Ladd, A. A. B. L., Ribeiro, A. A. C. M., & Augusto, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055868 · Cited by 24
3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents
Telpoukhovskaia, M. A., Rodríguez‐Rodríguez, C., Cawthray, J. F., Scott, L. E., Page, B. D. G., Alí‐Torres, J., Sodupe, M., Bailey, G. A., Patrick, B. O., & Orvig, C. (2013) · Metallomics · doi:10.1039/c3mt00135k · Cited by 24
Synthesis of donepezil-based multifunctional agents for the treatment of Alzheimer’s disease
Yerdelen, K. Ö., Koca, M., Anıl, B., Sevindik, H. G., Kasap, Z., Halıcı, Z., Turkaydin, K., & Gunesacar, G. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.10.051 · Cited by 24
Copper(II) complexation of tacrine hybrids with potential anti-neurodegenerative roles
Quintanova, C., Keri, R. S., Chaves, S., & Santos, M. A. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.06.008 · Cited by 23
Wang, Z., Xie, S., Li, X., Wu, J., Wang, X., & Kong, L. (2015) · RSC Advances · doi:10.1039/c5ra13594j · Cited by 23
Maher, P. A., & Kontoghiorghes, G. J. (2015) · Neurochemical Research · doi:10.1007/s11064-014-1508-7 · Cited by 23
Simple animal models for amyotrophic lateral sclerosis drug discovery
Patten, S. A., Parker, J. A., Wen, X., & Drapeau, P. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1196183 · Cited by 23
Lim, L., & Song, J. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.06.027 · Cited by 23
Li, L., Xu, S., Liu, L., Feng, R., Gong, Y., Zhao, X., Li, J., Cai, J., Feng, N., Wang, L., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160587 · Cited by 23
Diphenylpropynone derivatives as probes for imaging β-amyloid plaques in Alzheimer’s brains
Ono, M., Watanabe, H., Watanabe, R., Haratake, M., Nakayama, M., & Saji, H. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.11.058 · Cited by 22
Dhanjal, J. K., Goyal, S., Sharma, S., Hamid, R., & Grover, A. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.088 · Cited by 21
Liu, J., Hu, G., Xu, R., Qiao, Y., Wu, H.-P., Ding, X., Duan, P., Tu, P., & Lin, Y. (2013) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2013.800972 · Cited by 21
Homoisoflavonoids as potential imaging agents for β-amyloid plaques in Alzheimer's disease
Gan, C., Zhao, Z., Nan, D., Yin, B., & Hu, J. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.02.020 · Cited by 20
Márquez, M., Blancas‐Mejía, L. M., Campos, A., Rojas-Ochoa, L. F., Castañeda‐Hernández, G., & Quintanar, L. (2014) · Metallomics · doi:10.1039/c4mt00257a · Cited by 20
Somavarapu, A. K., Shen, F., Teilum, K., Zhang, J., Mossin, S., Thulstrup, P. W., Bjerrum, M. J., Tiwari, M. K., Szunyogh, D., Søtofte, P. M., et al. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201703440 · Cited by 20
Mori, F., Kakita, A., Takahashi, H., & Wakabayashi, K. (2013) · Neuropathology · doi:10.1111/neup.12044 · Cited by 19
Schiewe, A. J., Margol, L., Soreghan, B. A., Thomas, S. N., & Yang, A. J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000032994.36343.02 · Cited by 19
Monoamine oxidase and α-synuclein as targets in Parkinson’s disease therapy
Follmer, C. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.920235 · Cited by 18
Zheng, W., Li, J., Qiu, Z., Xia, Z., Li, W., Yu, L., Chen, H., Chen, J., Chen, Y., Hu, Z., et al. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.07.018 · Cited by 18
Park, J., Ahn, J. S., Lee, J., Bhak, G., Jung, S., & Paik, S. R. (2008) · ChemBioChem · doi:10.1002/cbic.200800343 · Cited by 18
Identification of multifunctional small molecule-based reversible monoamine oxidase inhibitors
Geldenhuys, W. J., Ko, K. S., Stinnett, H., der Schyf, C. J. V., & Lim, M. H. (2011) · MedChemComm · doi:10.1039/c1md00176k · Cited by 18
Self-citationQi, X., ZHANG, Y.-X., Liu, D.-G., Chan, P., Xu, S., & Cui, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5166 · Cited by 18
Das, S., & Smid, S. D. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.02.057 · Cited by 18
New hydroxypyridinone iron-chelators as potential anti-neurodegenerative drugs
Arduíno, D., Silva, D., Cardoso, S. M., Chaves, S., Oliveira, C. R., & Santos, M. A. (2008) · Frontiers in bioscience · doi:10.2741/3187 · Cited by 17
Ming, L., & Valentine, J. S. (2014) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-014-1126-5 · Cited by 17
Small‐Molecule‐Induced Soluble Oligomers of α‐Synuclein with Helical Structure
Fonseca‐Ornelas, L., Schmidt, C., Camacho‐Zarco, A. R., Fernández, C. O., Becker, S., & Zweckstetter, M. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201703001 · Cited by 17
Solsona, C., Kahn, T. B., Badilla, C. L., Álvarez-Zaldiernas, C., Blasi, J., Fernández, J. M., & Alegre‐Cebollada, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.565333 · Cited by 16
Porter, M. R., Kochi, A., Karty, J. A., Lim, M. H., & Zaleski, J. M. (2014) · Chemical Science · doi:10.1039/c4sc01979b · Cited by 16
Self-citationTelpoukhovskaia, M. A., Cawthray, J. F., Rodríguez‐Rodríguez, C., Scott, L. E., Page, B. D. G., Patrick, B. O., & Orvig, C. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.059 · Cited by 15
Characterization of Radioiodinated Ligand Binding to Amyloid β Plaques
Kung, M., Zhuang, Z., Hou, C., Jin, L., & Kung, H. F. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:249 · Cited by 15
TDP-43 modification in the hSOD1G93Aamyotrophic lateral sclerosis mouse model
Cai, M., Lee, K., Choi, S., & Yang, E. J. (2014) · Neurological Research · doi:10.1179/1743132814y.0000000443 · Cited by 15
Jiang, N., Wang, X., Li, Z., Li, S., Xie, S., Huang, M. Y., & Kong, L. (2015) · RSC Advances · doi:10.1039/c4ra10692j · Cited by 15
Effects of small-molecule amyloid modulators on a Drosophila model of Parkinson’s disease
Pokrzywa, M., Pawełek, K., Kucia, W. E., Sarbak, S., Chorell, E., Almqvist, F., & Wittung-Stafshede, P. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184117 · Cited by 15
Skibiński, R., Czarnecka, K., Girek, M. K., Bilichowski, I., Chufarova, N. V., Mikiciuk‐Olasik, E., & Szymański, P. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13111 · Cited by 15
Beck, M. W., Derrick, J. S., Suh, J., Kim, M., Korshavn, K. J., Kerr, R. A., Cho, W. J., Larsen, S. D., Ruotolo, B. T., Ramamoorthy, A., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700456 · Cited by 15
Self-citationKubo, S. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1086340 · Cited by 12
cAMP-specific phosphodiesterases expression in Alzheimer's disease brains
Pérez-Torres, S., & Mengod, G. (2003) · International Congress Series · doi:10.1016/s0531-5131(03)00104-3 · Cited by 12
Cyclam glycoconjugates as lectin ligands and protective agents of metal-induced amyloid aggregation
Lanza, V., D’Agata, R., Iacono, G., Bellia, F., Spoto, G., & Vecchio, G. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.06.016 · Cited by 11
Structure–activity relationship of cyclic thiacarbocyanine tau aggregation inhibitors
Schafer, K. N., Murale, D. P., Kim, K., Cisek, K. K., Kuret, J., & Churchill, D. G. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.04.039 · Cited by 10
Evans, T. M., Bhattacharya, A., Shi, Y., Qi, W., Block, T. J., Chaudhuri, A. R., Chaudhuri, A. R., Hawker, K., & Remmen, H. V. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.035 · Cited by 10
Kim, H.-K., Chung, Y. W., Chock, P. B., & Yim, M. B. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.02.014 · Cited by 9
A small bifunctional chelator that modulates Aβ42 aggregation
Zhang, C., Gomes, L. M., Zhang, T., & Storr, T. (2017) · Canadian Journal of Chemistry · doi:10.1139/cjc-2017-0623 · Cited by 8
Guan, L., Hao, Y., Chen, L., Wei, M., Jiang, Q., Liu, W., Zhang, Y., Zhang, J., Feng, F., & Qu, W. (2016) · RSC Advances · doi:10.1039/c5ra21313d · Cited by 6
(2001) · doi:10.1002/1521-3773(20010618)40:12<2274::aid-anie2274>3.0.co;2-5
Cited by
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease
Bai, R., Guo, J., Ye, X.-Y., Xie, Y., & Xie, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101619 · Cited by 813
Yang, B., Chen, Y., & Shi, J. (2019) · Advanced Materials · doi:10.1002/adma.201901778 · Cited by 601
Energy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L.-L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 399
Pathological mechanisms and therapeutic strategies for Alzheimer’s disease
Tam, K., & Ju, Y. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.320970 · Cited by 395
Metadata
- Authors
- Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-08-10
- Volume
- 119
- Issue
- 2
- Pages
- 1221-1322
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2886819196
- Cited by
- 581
- References
- 1,155
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.